Skip to main content

Month: February 2021

Eledon Pharmaceuticals to Present at 10th Annual SVB Leerink Global Healthcare Conference

IRVINE, Calif., Feb. 17, 2021 (GLOBE NEWSWIRE) — Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN), a clinical stage biopharmaceutical company focused on developing life-changing, targeted medicines for persons undergoing organ or cellular transplantation, as well as those living with immunological diseases, today announced that David-Alexandre C. Gros, M.D., Eledon’s CEO, will present at the 10th annual SVB Leerink Global Healthcare Conference, on Wednesday, February 24that 4:20 p.m. EST. The live webcast of Eledon’s presentation can be accessed on the investors section of its website at www.eledon.com, and by registering here; a replay will be available for 90 days.About Eledon Pharmaceuticals and AT-1501Eledon Pharmaceuticals (f/k/a Novus Therapeutics, Inc.) is a clinical stage biotechnology company using its expertise in...

Continue reading

AREV’s Nanotech initiates early-stage antiviral photochemistry derivation discovery program for pandemic viral pathogens

VANCOUVER, British Columbia, Feb. 17, 2021 (GLOBE NEWSWIRE) — AREV NANOTEC BRANDS INC. (CSE: AREV) (OTC: AREVF) (“AREV Nanotec”), is pleased to announce that AREV is utilizing its proprietary extraction technologies and facilitating initial efforts to identify broad spectrum antiviral agents derived from medicinal photochemistry sources including bioactive compounds sourced from Moringa oleifera and Moringa ovalifolia, identified in peer-reviewed publications as presenting a wide range of antiviral activity, and may demonstrate high affinity with viral protease inhibition.“In response to the COVID-19 pandemic AREV is pursuing collaborations with a number of world renowned University centers to facilitate advanced extraction of potential antiviral phytochemicals from medicinal plant libraries for screening specific small molecules...

Continue reading

Cloud based contact center Market to Reach USD 56.37 billion by 2028

Pune, India, Feb. 17, 2021 (GLOBE NEWSWIRE) — The global cloud based contact center market size is projected to exhibit flourishing growth owing to the increasing utilization of artificial intelligence in the development of the product, observes Fortune Business Insights™ in its report, titled, “Cloud Based Contact Center Market Size, Share & COVID-19 Impact Analysis, By Component (Solutions and Services), By Deployment (Public, Private, and Hybrid), By Organization Size (Large Organizations, Small and Medium-Sized Organizations), By Vertical (Banking, Financial Services, and Insurance, ITES, IT and Telecom, Government, Healthcare, Consumer Goods and Retail, Travel and Hospitality, Media and Entertainment and Others) and Regional Forecast, 2021-2028” The market stood at USD 11.01 billion in 2021 and is projected to reach USD...

Continue reading

Marimaca Copper Identifies Large Surface Geochemical Anomaly at Cindy Target

VANCOUVER, British Columbia, Feb. 17, 2021 (GLOBE NEWSWIRE) — Marimaca Copper Corp. (“Marimaca Copper” or the “Company”)(TSX: MARI) is pleased to announce the results of a recently completed rock geochemistry and reconnaissance mapping program at the Cindy Target, which is located 5km to the north of the Company’s flagship Marimaca Copper Project .HighlightsGeochemical sampling has identified a very large copper anomaly with grades as high as 2.9% Cu°  Greater than 200ppm Cu anomaly extending over 1km of strike, several ore grade samples noted°  Coincident with historical underground artisanal workings exploiting high grade magnetite-chalcopyrite mineralization°  A significant proportion of the Cindy Target is concealed by post mineral gravels, similar to the Mercedes Target    •  The geochemical anomaly is potentially larger than...

Continue reading

PureK Holdings Corp. Signs Definitive Agreement to Acquire ‘BudaPets’ All-Natural Pet Wellness Brand

VANCOUVER, British Columbia, Feb. 17, 2021 (GLOBE NEWSWIRE) — PureK Holdings Corp‎. (the “Company” or “PureK“) (TSX Venture: PKAN) is pleased to announce that it has executed a definitive agreement (the “Agreement“) with Felicity Management Group LLC, Rhodes Management Corp. and 2443904 Ontario Inc. (collectively, the “Sellers“), to acquire all of the outstanding membership interests of Nirvana Group, LLC (“Nirvana“), a Florida-based company specializing in the development, manufacturing, and distribution of all-natural pet wellness products and which includes the BudaPets brand.According to a recent report from Fior Markets, the global pet care industry is expected to reach approximately $358.6 billion by 2027, at a compound annual growth rate (CAGR) of six percent.1 Another...

Continue reading

Solid Biosciences to Present at Upcoming Investor Conferences

CAMBRIDGE, Mass., Feb. 17, 2021 (GLOBE NEWSWIRE) — Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company focused on advancing meaningful therapies for Duchenne muscular dystrophy (Duchenne), today announced that Joel Schneider, PhD, Chief Technology Officer, and Cathryn Clary, MD, MBA, Acting Chief Medical Officer, will participate at the following two upcoming investor conferences:SVB Leerink 10th Annual Global Healthcare ConferenceFireside chat on Wednesday, February 24, 2021 at 1:40 p.m. ET.Barclays Global Healthcare ConferenceFireside chat on Thursday, March 11, 2021 at 9:45 a.m. ET.A live webcast of these presentations will be available on the Company’s investor relations website, under the Events page accessible here: https://investors.solidbio.com/news-and-events/events. A replay will be available on the Company’s...

Continue reading

Harpoon Therapeutics to Participate in SVB Leerink Global Healthcare Conference

SOUTH SAN FRANCISCO, Calif., Feb. 17, 2021 (GLOBE NEWSWIRE) — Harpoon Therapeutics, Inc. (NASDAQ: HARP), a clinical-stage immunotherapy company developing a novel class of T cell engagers, today announced that Gerald McMahon, Ph.D., President and Chief Executive Officer, will participate in a fireside chat at the SVB Leerink 10th Annual Global Healthcare Conference. The discussion will take place on Wednesday, February 24, 2021 at 4:20 p.m. ET (1:20 p.m. PT).A live audio webcast of the fireside chat will be available in the Investors section of Harpoon Therapeutics’ website at www.harpoontx.com with an archived replay available following the event.About Harpoon TherapeuticsHarpoon Therapeutics is a clinical-stage immunotherapy company developing a novel class of T cell engagers that harness the power of the body’s immune system...

Continue reading

Mandalay Resources Corporation Announces Significant Grades and Depth Extension to the Lake Zone Veining of the Björkdal Deposit

TORONTO, Feb. 17, 2021 (GLOBE NEWSWIRE) — Mandalay Resources Corporation (“Mandalay” or the “Company”) (TSX: MND, OTCQB: MNDJF) is pleased to provide an update on the encouraging results from the Björkdal Depth Testing drilling program.Björkdal Depth Testing Highlights15 veins containing significant grades have been intercepted with inferred strike extensions of up to and over 300 meters (“m”)Standout intercepts identified:○ 92.2 g/t gold over a true width of 0.40 m in MU20-021;○ 32.5 g/t gold over a true width of 1.1 m in MU20-021;○ 16.4 g/t gold over a true width of 1.11 m in MU20-022;○ 119.2 g/t gold over a true width of 0.44 m in MU20-023; and○ 58.5 g/t gold over a true width of 0.32 m in MU20-025.Identified skarnified marble lens:○ 3.4 g/t gold over a true width of 5.01 m in MU20-024Note: Significant...

Continue reading

Kura Oncology to Report Fourth Quarter and Full Year 2020 Financial Results

SAN DIEGO, Feb. 17, 2021 (GLOBE NEWSWIRE) — Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced that it will report fourth quarter and full year 2020 financial results before the open of U.S. financial markets on Wednesday, February 24, 2021. Kura’s management will host a webcast and conference call at 8:00 a.m. ET / 5:00 a.m. PT that day to discuss the financial results and provide a corporate update.The live call may be accessed by dialing (877) 516-3514 for domestic callers and (281) 973-6129 for international callers and entering the conference code: 8581798. A live webcast and archive of the call will be available online from the investor relations section of the company website at www.kuraoncology.com.Kura...

Continue reading

Falco Resources to Attend BMO Global Metals & Mining Conference and the Prospectors & Developers Association of Canada (PDAC)

MONTREAL, Feb. 17, 2021 (GLOBE NEWSWIRE) — Falco Resources Ltd. Falco” or the “Corporation”) (TSX-V: FPC) is pleased to announce that it will be participating in two upcoming conferences.BMO 30TH GLOBAL METALS & MINING CONFERENCEVirtual EditionMarch 1-5, 2021BMO Global Metals & Mining Conference is one of the sector’s premier events. This five-day invitation-only conference brings together mining industry leaders and institutional investors from around the globe.Luc Lessard, President and Chief Executive Officer of Falco, will present at the BMO Global Metals & Mining Conference on Thursday, March 4 at 11:45am and will be available for one-on-one meetings throughout the conference. Meeting requests can be made through the conference website.PROSPECTORS & DEVELOPERS ASSOCIATION OF CANADA (PDAC)Virtual EditionMarch...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.